BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25234253)

  • 21. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.
    Ragunath K; Krasner N; Raman VS; Haqqani MT; Phillips CJ; Cheung I
    Scand J Gastroenterol; 2005 Jul; 40(7):750-8. PubMed ID: 16118910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Visser M; Ten Kate FJ; van Berge Henegouwen MI; Schoon EJ; Weusten BL; Bergman JJ
    Endoscopy; 2012 Dec; 44(12):1096-104. PubMed ID: 23108809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical impact of conventional endosonography and endoscopic ultrasound-guided fine-needle aspiration in the assessment of patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma who have been referred for endoscopic ablation therapy.
    Shami VM; Villaverde A; Stearns L; Chi KD; Kinney TP; Rogers GB; Dye CE; Waxman I
    Endoscopy; 2006 Feb; 38(2):157-61. PubMed ID: 16479423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endoscopic Treatment of High-Grade Dysplasia and Intramucosal Esophageal Adenocarcinoma.
    Reed CC; Shaheen NJ
    J Laparoendosc Adv Surg Tech A; 2016 Oct; 26(10):768-772. PubMed ID: 27541732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Barrett's oesophagus, dysplasia and early adenocarcinoma.
    Pech O; Gossner L; May A; Ell C
    Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):267-84. PubMed ID: 11355915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
    Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW;
    Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer].
    Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fékété F
    Bull Acad Natl Med; 2000; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system.
    Gondrie JJ; Pouw RE; Sondermeijer CM; Peters FP; Curvers WL; Rosmolen WD; Ten Kate F; Fockens P; Bergman JJ
    Endoscopy; 2008 May; 40(5):370-9. PubMed ID: 18494132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic mucosal resection versus esophagectomy for intramucosal adenocarcinoma in the setting of barrett's esophagus.
    Li C; Yamashita DT; Hawel JD; Bethune D; Henteleff H; Ellsmere J
    Surg Endosc; 2017 Oct; 31(10):4211-4216. PubMed ID: 28342132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophagectomy for failed endoscopic therapy in patients with high-grade dysplasia or intramucosal carcinoma.
    Hunt BM; Louie BE; Dunst CM; Lipham JC; Farivar AS; Sharata A; Aye RW
    Dis Esophagus; 2014; 27(4):362-7. PubMed ID: 23795720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic treatment of Barrett's esophagus: From metaplasia to intramucosal carcinoma.
    Chennat J; Waxman I
    World J Gastroenterol; 2010 Aug; 16(30):3780-5. PubMed ID: 20698040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and predictors of adenocarcinoma following endoscopic ablation of Barrett's esophagus.
    Yasuda K; Choi SE; Nishioka NS; Rattner DW; Puricelli WP; Tramontano AC; Kitano S; Hur C
    Dig Dis Sci; 2014 Jul; 59(7):1560-6. PubMed ID: 24395382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic removal or ablation of oesophageal and gastric superficial tumours.
    Deprez PH; Aouattah T; Piessevaux H
    Acta Gastroenterol Belg; 2006; 69(3):304-11. PubMed ID: 17168128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett's neoplasia.
    Chevaux JB; Piessevaux H; Jouret-Mourin A; Yeung R; Danse E; Deprez PH
    Endoscopy; 2015 Feb; 47(2):103-12. PubMed ID: 25412090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach.
    May A; Gossner L; Pech O; Fritz A; Günter E; Mayer G; Müller H; Seitz G; Vieth M; Stolte M; Ell C
    Eur J Gastroenterol Hepatol; 2002 Oct; 14(10):1085-91. PubMed ID: 12362099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic mucosal resection for staging and therapy of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.
    Heinrich H; Bauerfeind P
    Recent Results Cancer Res; 2010; 182():85-91. PubMed ID: 20676873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy.
    Luna RA; Gilbert E; Hunter JG
    Curr Opin Gastroenterol; 2012 Jul; 28(4):362-9. PubMed ID: 22517568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal selection and persistence in dysplastic Barrett's esophagus and intramucosal cancers after failed radiofrequency ablation.
    Zeki SS; Haidry R; Graham TA; Rodriguez-Justo M; Novelli M; Hoare J; Dunn J; Wright NA; Lovat LB; McDonald SA
    Am J Gastroenterol; 2013 Oct; 108(10):1584-92. PubMed ID: 23939625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
    Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
    Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.